Back

Life expectancy and determinants of relative survival following surgical aortic valve replacement for aortic stenosis

1 September 2025 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Improving prognosis after TAVI Prosthetic Heart Valves ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Steele Butcher

Royal Perth Hospital, Perth (Australia)

5 More presentations in this session

Presentation thumbnail
Association between sex and transcatheter aortic valve replacement outcome for bicuspid and tricuspid aortic stenosis
Doctor J. He (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Impact of obstructive coronary artery disease on clinical and health status in patients undergoing transcatheter aortic valve implantation
Doctor D. Tomii (Bern, CH)
Abstract Slides
Presentation thumbnail
Impact of balloon-expandable valve asymmetry index on heart failure following transcatheter aortic valve replacement
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides
Presentation thumbnail
Sex-related disparities in prognosis and clinical progression in patients with type 2 diabetes and degenerative aortic stenosis
Doctor S. Kontogeorgos (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Association between quality of care indicators and clinical outcomes in patients undergoing transcatheter aortic valve implantation: insights from SWEDEHEART
Doctor K. Nilsson (Uppsala, SE)
Abstract Slides

Access the full session

Session thumbnail
Improving prognosis after TAVI
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Baseline frailty predicts 10-year survival in octogenarian patients after aortic valve replacement
thumbnail
Congress Presentation
Long-term outcomes of TAVI in patients with cancer: insights into early and late mortality trends
thumbnail
Congress Presentation
Long-term mortality in patients who survive 90 days after surgery for infective endocarditis versus the background population: a nationwide study.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources